Daniel E. Levy, Ph.D.
Dr. Levy received his academic degrees from the University of California - Berkeley (B.S., 1987) and the Massachusetts Institute of Technology (Ph.D., 1992). Since 1992, Dr. Levy worked in the biopharmaceutical industry designing novel treatments for indications which included:
-Cancer
-Inflammation
-Multiple Sclerosis
-Alzheimer's Disease
-Deep Vein Thrombosis
-Congestive Heart Failure
-Arrhythmia
Having worked at companies of all sizes, Dr. Levy was most recently the Director of Synthetic Chemistry at Intradigm Corporation pursuing delivery vehicles for siRNA therapeutics. Previous employers include Glycomed Inc., COR Therapeutics, Scios, Inc., and Intradigm, Inc.
Dr. Levy has extensive experience in all aspects of organic and medicinal chemistry having led and contributed to programs targeting:
-Kinases
-GPCRs
-ADP Receptors
-Steroid Receptors
-Matrix Metalloproteinases
-Cell Adhesion Molecules
Through his efforts, Dr. Levy designed and developed syntheses for novel chemical entities from various chemical and pharmaceutical classes including:
-Glycomimetics
-Peptidomimetics
-Sugar analogs
-Nucleoside analogs
-Steroids
-Heterocycles
-PEGs (monofunctional, bifunctional and heterobifunctional)
-Lipids
In addition to his corporate activities, Dr. Levy, in collaboration with Dr. Péter Fügedi, developed and presented ACS short courses entitled:
-Modern Synthetic Carbohydrate Chemistry
-The Organic Chemistry of Sugars
Dr. Levy is author and editor of four books:
-Arrow Pushing in Organic Chemistry: An Easy Approach to Understanding Reaction Mechanisms
-The Organic Chemistry of Sugars
-The Chemistry of C-Glycosides
Please visit Dr. Levy's public profile on Linked-in
https://www.linkedin.com/in/daniel-levy-644a17/
COMMUNICATIONS
Copyright Daniel E. Levy, All Rights Reserved